Exicure Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
It's my pleasure to introduce our next guest from Exicure, Chief Executive Officer, Dr. David Giljohann. The format for the session is a roughly 25 minute fireside chat. (Conference Instructions). So David, welcome. To start, could you provide a couple minutes of introductory comments about the state of the business for Exicure, summarizing your differentiated approach and what's been achieved in 2021 year to date?
Sure thing. Thanks, happy to be here, and thanks to everybody that's joining and watching along. So again my name is David Giljohann; I'm the CEO of Exicure and on behalf of the entire Exicure team, happy to be here presenting about our technology and our Company.
So Exicure is publicly traded under the ticker symbol XCUR and I think we've had a great year for those that have been following along. And of course, as we're looking towards the future, I think many more things for us to look forward to.
For this year, [Jay], everything at Exicure has been about neuro,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |